Ra Pharmaceuticals to Present at the Cantor Fitzgerald Global Healthcare Conference
September 20 2017 - 7:12AM
Business Wire
Ra Pharmaceuticals, Inc. (NASDAQ:RARX), a clinical stage
biopharmaceutical company focusing on the development of
next-generation therapeutics for the treatment of
complement-mediated diseases, today announced that Doug Treco,
Ph.D., President and Chief Executive Officer, will present at
the Cantor Fitzgerald Global Healthcare Conference
on Wednesday, September 27, 2017 at 10:55 a.m. E.T.
The conference is being held at the InterContinental New York
Barclay Hotel.
The presentation will be webcast live and can be accessed by
visiting the investor relations section of the Company’s
website, www.rapharma.com. A replay of the presentation will
also be available and archived on the site for three weeks.
About Ra Pharmaceuticals
Ra Pharmaceuticals is a clinical stage biopharmaceutical
company focusing on the development of next-generation therapeutics
for complement-mediated diseases. The Company discovers and
develops peptides and small molecules to target key components of
the complement cascade. For more information, please visit:
www.rapharma.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170920005320/en/
Investors:Ra Pharmaceuticals, Inc.Jennifer Robinson,
617-674-9873jrobinson@rapharma.comorMedia:Argot PartnersEliza
Schleifstein, 917-763-8106eliza@argotpartners.com
Ra Pharmaceuticals (NASDAQ:RARX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Ra Pharmaceuticals (NASDAQ:RARX)
Historical Stock Chart
From Apr 2023 to Apr 2024